Recall of Philips Respironics Trilogy Evo Ventilator
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Philips Respironics is recalling 113,717 units of its Trilogy Evo ventilator due to potential discrepancies in tidal volume when using certain nebulizers.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 9, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-devices.
Areazine reports on a product recall initiated by Philips Respironics, Inc. This article provides factual details based on official FDA information.
What Happened
The recall is due to the potential for a discrepancy between the set tidal volume and the tidal volume received by the patient when using non-pneumatic nebulizers with the Trilogy Evo Platform ventilators. This issue was identified as a voluntary firm-initiated action.
Which Products Are Affected
The affected products are the Philips Respironics Trilogy Evo ventilators with Software Version 1.05.15.00. This includes all model numbers, all Unique Device Identifiers (UDI), and all serial numbers. A total of 113,717 units are involved in this recall. The products were distributed nationwide in the United States and to numerous other countries worldwide.
What You Should Do
Consumers who have the affected Trilogy Evo ventilators should follow the instructions in the initial notification letter from Philips Respironics, Inc. For further information, contact the recalling firm at their address: 1001 Murry Ridge Ln, Murrysville, PA 15668-8517.
Why This Matters
This recall addresses a potential risk in medical devices that could affect patient treatment, highlighting the importance of accurate ventilator performance for home-use respiratory support in just a few sentences.
Source
Information sourced from the FDA. For more details, visit the FDA website at https://www.fda.gov and reference recall number Z-1614-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,515 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.